Open AccessRadical Prostatectomy after Vascular Targeted Photodynamic Therapy with Padeliporfin: Feasibility, and Early and Intermediate Results
Author(s) -
V. Pierrard,
Souhil Lebdai,
F. Kleinclauss,
Abdel-Rahmène Azzouzi,
J. Terrier,
E. Fortier,
Steven Joniau,
Henk G. van der Poel,
Georg Salomon,
J. Casanova,
R.A. Medina López,
E. Potiron,
J. Rigaud,
S. Vincendeau,
Jens Rassweiler,
Arnauld Villers,
Richard Gastón,
C. Saussine,
Joris Giai,
B. Gaillac,
Mark Emberton,
A. Ruffion
Publication year - 2018
Publication title -
the journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.402
H-Index - 256
eISSN - 1527-3792
pISSN - 0022-5347
DOI - 10.1016/j.juro.2018.08.084
Subject(s) - medicine , prostatectomy , urology , photodynamic therapy , oncology , prostate cancer , cancer , chemistry , organic chemistry
Vascular targeted photodynamic therapy with TOOKAD® is a new therapeutic option for localized prostate cancer management. The objectives of this study were to assess the feasibility of radical prostatectomy after vascular targeted photodynamic therapy and describe functional and oncologic outcomes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom